secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001628280-23-036376
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q3 revenue up 75% to $1.22B, MA members +58%; lowers FY23 MA membership guidance to 384-386K
--------------------------------------------------------------------------------

- Net loss $31M (unchanged YoY); Adj. EBITDA loss $6M vs. $26M loss last year.
- Medical margin $108M (+42% YoY) driven by MA growth; core markets excl. Hawaii saw $111M medical margin.
- Completed sale of MDX Hawaii (Oct 31) for undisclosed terms; focus on continental US partner markets.
- Updated FY23 guidance: MA members 384-386K (down from 412-415K), revenue $4.31-4.32B, adj. EBITDA $6-18M.
- ACO REACH contributed $18M to Adj. EBITDA in Q3; expects $39M for FY23 (up from prior $30-35M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828023036376/0001628280-23-036376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828023036376/agl-20231102.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-036376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer